The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (123.55) USD. With the latest stock price at 5.62 USD, the upside of FibroGen Inc based on DCF is -2298.4%.
Based on the latest price of 5.62 USD and our DCF valuation, FibroGen Inc (FGEN) is a sell. selling FGEN stocks now will result in a potential gain of 2298.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 19.7% | 12.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,333.53) - (74.61) | (123.55) |
| Upside | -23828.2% - -1427.6% | -2298.4% |